Clinical trials regulations
The current tendency is to provide subjects for clinical trials with very detailed informed consent documents, some of which can run to 15 pages and contain fairly
technical medical terms. Some of these informed consent documents are probably only poorly understood by potential subjects and may even scare some subjects away.
Which do you think would be a better policy – the current policy of being totally transparent and providing detailed information to potential subjects, or a policy of
providing less, but perhaps more understandable, information. Explain why you feel one or the other policy would be better.
PLACE THIS ORDER OR A SIMILAR ORDER WITH US TODAY AND GET AN AMAZING DISCOUNT ?